Sign In
Buy IRWD
$3.24
-0.0400 (-1.22%)
At Close: Jun 03, 2026
Ironwood Pharmaceuticals (NASDAQ:IRWD) & CytoDyn (OTCMKTS:CYDY) Critical Survey
01:46am, Tuesday, 10'th Feb 2026
CytoDyn (OTCMKTS:CYDY - Get Free Report) and Ironwood Pharmaceuticals (NASDAQ: IRWD - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two busi
3 Stocks Trading Near $5 With Massive Earnings Upside
08:28am, Sunday, 08'th Feb 2026
Contrary to what investors have seen this earnings season, earnings growth is traditionally one of the key indicators of stock price growth. For calendar year 2026, FactSet forecasts earnings growth
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption?
09:51am, Thursday, 05'th Feb 2026
IRWD expects Linzess demand to accelerate, driving a bullish 2026 outlook with revenue growth, higher profits and expanding adoption.
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Passes Above 200 Day Moving Average – Time to Sell?
04:10am, Friday, 30'th Jan 2026
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $2.30 and tr
4 Stocks Trading Near 52-Week High With More Upside Potential
11:36am, Friday, 23'rd Jan 2026
Stocks like IPGP, DG, IRWD and SAIC are seeing price strength and have a high chance of carrying the momentum forward.
Ironwood Pharmaceuticals' 2026 Guidance Shock Sparks a Major Re-Rating
03:25pm, Wednesday, 07'th Jan 2026
The pharmaceutical sector is famously volatile, usually driven by the binary outcomes of clinical trials. A drug either works, sending the stock to the moon, or it fails, causing a crash.
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
09:46am, Wednesday, 07'th Jan 2026
Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026
11:31am, Monday, 05'th Jan 2026
IRWD shares jump on upbeat 2026 revenue guidance amid rising Linzess demand in the United States. The company also provides a key pipeline update.
U.S. stock futures rose in the first full trading week of the year on Monday after closing mixed on Friday. Futures of major benchmark indices were higher.
Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month High After Analyst Upgrade
01:55am, Sunday, 04'th Jan 2026
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD - Get Free Report)'s stock price hit a new 52-week high during trading on Friday after Zacks Research upgraded the stock from a hold rating to a strong-buy
Ironwood Pharma (IRWD) Surges on Strong FY26 Guidance and Pipeline Updates
01:14pm, Friday, 02'nd Jan 2026
Ironwood Pharma (IRWD) is reaching a new 52-week high after reaffirming its FY25 guidance and releasing robust FY26 guidance. For FY25, IRWD anticipates total r
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
07:05am, Friday, 02'nd Jan 2026
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report?
12:30pm, Wednesday, 10'th Dec 2025
Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock?
Ironwood Pharmaceuticals (NASDAQ:IRWD) versus Citius Pharmaceuticals (NASDAQ:CTXR) Critical Analysis
03:16am, Saturday, 29'th Nov 2025
Ironwood Pharmaceuticals (NASDAQ: IRWD - Get Free Report) and Citius Pharmaceuticals (NASDAQ: CTXR - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will com
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
01:01pm, Thursday, 27'th Nov 2025
Ironwood and Puma Biotechnology are advancing therapies for gastrointestinal disorders and cancer, respectively. Rising sales of key drugs fuel 2026 prospects.
